全文获取类型
收费全文 | 935篇 |
免费 | 24篇 |
专业分类
电工技术 | 13篇 |
化学工业 | 112篇 |
金属工艺 | 10篇 |
机械仪表 | 11篇 |
建筑科学 | 11篇 |
能源动力 | 6篇 |
轻工业 | 59篇 |
水利工程 | 1篇 |
石油天然气 | 2篇 |
无线电 | 52篇 |
一般工业技术 | 86篇 |
冶金工业 | 534篇 |
原子能技术 | 8篇 |
自动化技术 | 54篇 |
出版年
2021年 | 5篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 11篇 |
2017年 | 7篇 |
2016年 | 9篇 |
2015年 | 5篇 |
2014年 | 13篇 |
2013年 | 15篇 |
2012年 | 24篇 |
2011年 | 32篇 |
2010年 | 24篇 |
2009年 | 21篇 |
2008年 | 26篇 |
2007年 | 31篇 |
2006年 | 16篇 |
2005年 | 16篇 |
2004年 | 17篇 |
2003年 | 11篇 |
2002年 | 13篇 |
2001年 | 11篇 |
2000年 | 13篇 |
1999年 | 20篇 |
1998年 | 143篇 |
1997年 | 80篇 |
1996年 | 57篇 |
1995年 | 33篇 |
1994年 | 42篇 |
1993年 | 44篇 |
1992年 | 11篇 |
1991年 | 7篇 |
1990年 | 20篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 10篇 |
1986年 | 15篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1978年 | 6篇 |
1977年 | 27篇 |
1976年 | 40篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1973年 | 2篇 |
1972年 | 4篇 |
1937年 | 1篇 |
排序方式: 共有959条查询结果,搜索用时 89 毫秒
1.
NF Saba JD Sweeney LC Penn JC Lawton RL Yankee CH Huang MS Schanfield 《Canadian Metallurgical Quarterly》1997,37(3):321-324
PURPOSE: We report a case of postoperative reparalysis in the recovery room, following nebulized epinephrine. The patient was pharmacologically reversed with edrophonium after paralysis with rocuronium. CLINICAL FINDINGS: A 12-yr-old girl developed postoperative reparalysis following the intraoperative administration of rocuronium. A total of 0.92 mg.kg-1 rocuronium was administered. After surgery, pharmacological reversal was achieved with 20 mg edrophonium with 0.15 mg atropine sulfate iv 35 min after the last administration of rocuronium. Muscular relaxation was monitored using an ulnar peripheral nerve stimulator (PNS). After reversal, a full train-of-four and sustained tetanus at 50 Hz were present. In the recovery room, following nebulized epinephrine, the patient became apneic. The patient was paralyzed and an ulnar PNS demonstrated only one faint twitch. The paralysis was reversed with 1.5 mg neostigmine with 0.3 mg glycopyrrolate. CONCLUSION: Postoperative reparalysis following rocuronium may be a cause of postoperative respiratory distress. The definitive diagnosis is made using PNS and observing the response to pharmacological reversal. Nebulized epinephrine may have a previously undescribed role in the development of postoperative reparalysis. 相似文献
2.
3.
4.
An automotive engine oil viscosity sensor 总被引:1,自引:0,他引:1
For the evaluation of the condition of automotive engine oil, the oil's viscosity is one of the most important parameters. Using microacoustic viscosity sensors, an oil-viscosity measurement can be performed on-board. In this contribution, we discuss the behavior of the viscosity of engine oil, its temperature dependence, and the resulting representation in terms of output signals of microacoustic viscosity sensors. These considerations are illustrated by means of measurement results obtained for used oil samples, which have been obtained from test cars and fresh oil samples out of different viscosity classes. Finally, the detection of the viscosity increase due to soot contamination is demonstrated. 相似文献
5.
The Munich Community Health Service (Medical School-Service Department) conducted an alcohol prevention project in ten public secondary schools. The 423 pupils (11-17 years of age) filled in a questionnaire on alcohol and discussed it afterwards under the guidance of a school physician and a teacher using guideline information. The results of the survey are presented in this paper. Additionally, suggestions for transferring the results to conceptualize and carry out preventive measures are made. The results indicate that the first experience with alcohol occurred early in life. One-fifth of the sample had already tried alcohol at the age of six. Immediate effects of alcohol (e.g. state of drunkenness) were experienced by 35.7 percent of the sample group. Kiosks, shops, and beverage stores were named most frequently as sources for alcohol. The sources of social support varied with respect to sex and age. With increasing age of the children, parents were contacted less frequently whereas the role of peers increased. The present results supply possible paths of action for the development of successful prevention strategies, e.g. by pointing out the early age of onset as well as specific sources of alcohol acquisition. 相似文献
6.
FF Fassos J Klein D Fernandes D Matsui NF Olivieri G Koren 《Canadian Metallurgical Quarterly》1996,34(7):288-292
Recently, we demonstrated that administration of the orally active iron chelating agent deferiprone (1,2-dimethyl-3-hydroxypyrid-4-one (L1)) at 6-hour intervals results in significantly greater urinary iron excretion than that induced during administration of the drug at 12-hour intervals. That study was conducted in thalassemia patients, all of whom had received a packed red cell transfusion of 15 cc/kg. 72 hours prior to evaluation of urinary iron excretion, at a time when endogenous erythropoiesis would be expected to be at its lowest. In clinical practice however, thalassemia patients, suppression of endogenous erythropoiesis is not sustained between transfusions. We set out to determine the influence that administration of deferiprone has on urinary iron excretion at lower hemoglobin concentrations, immediately prior to transfusion. We hypothesized that hemoglobin levels will affect the ability of deferiprone to chelate iron. Ten regularly transfused patients with homozygous beta-thalassemia (HBT) aged mean +/- SD, 20.9 +/- 4.7, range 13 - 27 years, receiving long-term therapy with deferiprone, were treated with deferiprone 75 mg/kg/day, administered every 6 hours (or every 12 hours) for 72 hours immediately prior to a blood transfusion in the first month. One month later each patient received the other of the 2 dosing regimens for 72 hours immediately prior to transfusion. The deferiprone-induced 24-hour urinary iron excretion was similar during both dosing regimens; 0.56 +/- 0.45 mg/kg when L1 was given every 6 hours and 0.48 +/- 0.52 mg/kg when L1 was administered every 12 hours (p = 0.79). However, the calculated 24-hour area under the plasma concentration-time curve (AUC0-24) of deferiprone was significantly lower when deferiprone was administered at 6-hour intervals (6,762.8 +/- 1,601.6 mg*min/l), than that observed when deferiprone was administered every 12 hours (8,250.1 +/- 1,235.7 mg*min/l) (p = 0.04). The pharmacokinetics of deferiprone when administered immediately prior to transfusions are different from those following transfusions. More studies assessing total body iron excretion are needed to determine the contribution of the fecal route in iron excretion. 相似文献
7.
8.
9.
Structural investigation on proton-exchange membranes, obtained by the radiation grafting of styrene onto FEP films and subsequent sulfonation, was carried out by differential scanning calorimetry. The membrane crystallinity was found to show a decreasing trend with increasing degree of grafting. The melting temperature of all the membranes also showed a slight decrease as compared to the ungrafted FEP. The results have been explained in terms of the cumulative effect of the decrease in the crystalline/amorphous ratio by the incorporation of amorphous polystyrene grafts and of disruption of spherulitic crystallites of the FEP component in the membranes. The glass transition temperature of the membranes with different water contents was also evaluated. A correlation of the glass transition temperature with the residual water in dried membranes was established. © 1994 John Wiley & Sons, Inc. 相似文献
10.
JU Weaver L Thaventhiran K Noonan JM Burrin NF Taylor MR Norman JP Monson 《Canadian Metallurgical Quarterly》1994,41(5):639-648
OBJECTIVE: Growth hormone (GH) replacement therapy in hypopituitary adults is associated with sodium and water retention. The underlying mechanisms are incompletely understood and a possible contribution of altered cortisol metabolism or action has not been evaluated. We have investigated the effect of GH replacement therapy on cortisol metabolism, cortisol binding globulin and in-vitro glucocorticoid sensitivity in a group of adult hypopituitary patients. DESIGN AND PATIENTS: We studied 19 adult hypopituitary patients (18 adult onset, M:F, 6:13), who were receiving conventional hydrocortisone (16 patients), thyroxine (14 patients), triiodothyronine (1 patient), sex steroid (9 patients), human chorionic gonadotrophin (1 patient) or desmopressin (6 patients) replacement during a 6-month, double blind controlled trial of GH therapy (active:placebo, 8:11) followed by a 6-month open phase of GH (mean dose: 0.2 IU/kg/week, range 0.051-0.27) and after a 6-week washout phase following discontinuation of GH therapy. MEASUREMENTS: Twenty-four-hour urine free cortisol, cortisol metabolites (CoM), ratio 11-hydroxy/11-oxo CoM (F/E) and ratio 5 alpha/beta tetrahydrocortisol were measured at 6 months, 12 months and after the 6 week washout phase. Serum cortisol binding globulin was measured basally, at 6 months, 12 months and after washout. Glucocorticoid sensitivity was determined in lymphocyte preparations from 8 patients, during GH therapy and after washout, using an in-vitro technique dependent on dexamethasone suppression of phytohaemagglutinin-stimulated thymidine incorporation into DNA. Plasma renin activity and aldosterone were measured after 6-12 months GH therapy and after washout. RESULTS: After 6 months of GH, in patients on hydrocortisone (n = 9), there were significant decreases in CoM (mean decrement 21%, P < 0.01), F/E (mean decreased from 1.27 to 1.0, P = 0.04; reference range 0.33-1.29) and 5 alpha/5 beta tetrahydrocortisol (mean decreased from 0.67 to 0.48, P = 0.01) and a subsequent increase after washout. Patients not on hydrocortisone (n = 2) demonstrated a normal basal F/E falling by 25% on GH therapy but no change in CoM. During 12 months of GH therapy, patients on hydrocortisone (n = 7) demonstrated a further trend to decrement in CoM (P = 0.09) which reversed after washout (P = 0.04). Urine free cortisol tended to fall during GH therapy and increased significantly following washout after 12 months treatment (P < 0.02). Serum cortisol binding globulin decreased by 20% (P < 0.05) during 12 months GH treatment but remained within the reference range. In-vitro studies demonstrated a trend to reduced glucocorticoid sensitivity on GH therapy; the maximum inhibition of phytohaemagglutinin by dexamethasone tended to be less on GH therapy (P = 0.052) and was also lower than in 29 normal volunteers (P < 0.05). There were no significant changes in plasma renin but there was a small increment in aldosterone in recumbent patients (P = 0.04) during the open phase of GH therapy in the placebo arm. CONCLUSIONS: GH therapy in hypopituitary adults is associated with an apparent reduction in availability of administered hydrocortisone as measured by urine cortisol metabolites and urine free cortisol. This effect is unlikely to be clinically significant except possibly in ACTH deficient subjects on suboptimal hydrocortisone replacement. The changes in F/E suggest that GH may directly or indirectly modulate the activity of 11 beta-hydroxysteroid dehydrogenase. The apparent decrease in glucocorticoid sensitivity during GH therapy, demonstrated in vitro, merits further investigation. 相似文献